Trader consensus favors "No" at 75.5% implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the agency's current absence of any such alerts— the highest remain Level 2 for regional outbreaks like meningococcal disease in the Democratic Republic of the Congo (updated March 24, 2026) and yellow fever in Venezuela (March 16). Despite 1,814 confirmed U.S. measles cases across 22 outbreaks as of late April 2026, with 93% outbreak-associated, the global measles notice stays at Level 1, stressing MMR vaccination amid declining kindergartner rates. A(H5N1) bird flu surveillance shows no unusual human activity or sustained transmission. Epidemiological indicators fall short of Level 3 thresholds for widespread risk prompting nonessential travel avoidance, though new CDC surveillance updates could shift dynamics.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedCDC issues Level 3 warning by December 31?
CDC issues Level 3 warning by December 31?
$116,081 Vol.
$116,081 Vol.
$116,081 Vol.
$116,081 Vol.
A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Market Opened: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 3 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus favors "No" at 75.5% implied probability for a CDC Level 3 Travel Health Notice by December 31, driven by the agency's current absence of any such alerts— the highest remain Level 2 for regional outbreaks like meningococcal disease in the Democratic Republic of the Congo (updated March 24, 2026) and yellow fever in Venezuela (March 16). Despite 1,814 confirmed U.S. measles cases across 22 outbreaks as of late April 2026, with 93% outbreak-associated, the global measles notice stays at Level 1, stressing MMR vaccination amid declining kindergartner rates. A(H5N1) bird flu surveillance shows no unusual human activity or sustained transmission. Epidemiological indicators fall short of Level 3 thresholds for widespread risk prompting nonessential travel avoidance, though new CDC surveillance updates could shift dynamics.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions